Alchemia to start lung cancer drug trial
September 9th, 2011
From the Syndey Morning Herald
Biotechnology firm Alchemia has started to recruit patients for a phase II trial of its drug to treat small cell lung cancer.
Alchemia said on Friday that 40 patients will be recruited for the trial of the drug HA-Irinotecan, to be conducted at the Monash Cancer Centre and the Peninsula Oncology Centre in Melbourne.
This study will examine the effectiveness and safety of HA-Irinotecan.